Niki BioSolutions (NIKI) news
Recent news
Niki Biosolutions - May sell securities for aggregate offering price up to $75 mln - SEC filing
AInvest Wire · 3d agoNiki Biosolutions (not 'Aptorum') H1 basic EPS USD -1.6
Niki BioSolutions reported a basic earnings per share (EPS) of -$1.6 for the first half of 2026, reflecting continued financial challenges for the company. This figure aligns with the broader trend of negative EPS observed in recent years, with the company posting losses in most years since 2018.…
AInvest Wire · Aug 21, 2026Niki Biosolutions, Inc.: Niki Biosolutions in strategic pact to provide APOE testing services for progressive medical research
Niki Biosolutions, Inc. has entered into a strategic partnership to offer APOE gene testing services, supporting ongoing medical research related to Alzheimer’s disease risk factors. The APOE gene test identifies variants of the apolipoprotein E (APOE) gene, which may indicate an increased…
AInvest Wire · Jul 23, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.